pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 1,831 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Marketed
pembrolizumab
Keytruda (pembrolizumab)
Merkel Cell Carcinoma
Programmed cell death protein 1
$MRKMerck & Co., Inc.
125 catalysts
Marketed
nivolumab
Opdivo (nivolumab)
Colorectal Cancer
Programmed cell death protein 1
Bristol-Myers Squibb Co
86 catalysts
Marketed
goserelin LA
Zoladex (goserelin)
Metrorrhagia (Abnormal Uterine Bleeding)
← prev
page 1 of 62
next →
131
Pain89
Neurology1
TerSera Therapeutics LLC
76 catalysts
Marketed
triptorelin pamoate ER
Triptodur (triptorelin pamoate)
Central Precocious Puberty
Azurity Pharmaceuticals Inc
64 catalysts
Marketed
methylprednisolone sodium succinate
Methylprednisolone Sodium Succinate (methylprednisolone sodium succinate)
Drug Hypersensitivity Reactions
Sagent Pharmaceuticals Inc
48 catalysts
Marketed
Imatinib Mesylate Shilpa
Imatinib Mesylate (imatinib mesylate)
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
Armas Pharmaceuticals Inc
46 catalysts
Marketed
Spexotras
Mekinist (trametinib dimethyl sulfoxide)
Low-Grade Glioma
$NVSNOVARTIS AG
43 catalysts
Marketed
Efudex
Efudex (fluorouracil)
Basal Cell Carcinoma (Basal Cell Epithelioma)
Extrovis AG
42 catalysts
Marketed
METHYLPREDNISOLONE ACETATE
METHYLPREDNISOLONE ACETATE (METHYLPREDNISOLONE ACETATE)
Giant Cell Arteritis (Temporal Arteritis/Cranial Arteritis/Horton Disease)
Hong Kong King-Friend Pharmaceutical Co Ltd
41 catalysts
Marketed
atezolizumab
Tecentriq (atezolizumab)
Muscle Invasive Bladder Cancer (MIBC)
Programmed cell death 1 ligand 1
F. Hoffmann-La Roche Ltd
41 catalysts
Marketed
dabrafenib mesylate ODT
Tafinlar (dabrafenib mesylate)
Low-Grade Glioma
$NVSNOVARTIS AG
40 catalysts
Marketed
omeprazole DR
Prilosec (omeprazole)
Multiple Endocrine Adenomas
Covis Pharmaceuticals Inc (Inactive)
38 catalysts
Marketed
LEUPROLIDE ACETATE
LEUPROLIDE ACETATE (LEUPROLIDE ACETATE)
Gonadotropin-releasing hormone receptor
$AMRXAmneal Pharmaceuticals, Inc.
37 catalysts
Marketed
MEDROL
MEDROL (METHYLPREDNISOLONE)
Glucocorticoid receptor
$PFEPFIZER INC
34 catalysts
Marketed
Doxil
Doxil (doxorubicin hydrochloride)
Kaposi Sarcoma
$BAXBAXTER INTERNATIONAL INC
29 catalysts
Marketed
enzalutamide
Xtandi (enzalutamide)
Prostate Cancer
Alessa Therapeutics Inc
28 catalysts
Marketed
blinatumomab
Blincyto (blinatumomab)
B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia)
B-lymphocyte antigen CD19T cell surface glycoprotein CD3
$AMGNAMGEN INC
25 catalysts
Marketed
cabozantinib s-malate
Cometriq (cabozantinib s-malate)
Endometrial Cancer
Hepatocyte growth factor receptorVascular endothelial growth factor receptor 2
$EXELEXELIXIS, INC.
25 catalysts
Marketed
ZOLEDRONIC ACID
ZOLEDRONIC ACID (ZOLEDRONIC ACID)
Paget Disease of Bone
Avenacy Inc
22 catalysts
Marketed
venetoclax
Venclexta (venetoclax)
Mantle Cell Lymphoma
Apoptosis regulator Bcl-2
$ABBVAbbVie Inc.
22 catalysts
Marketed
selpercatinib
Retevmo (selpercatinib)
Anaplastic Thyroid Cancer
Coiled-coil domain-containing protein 6/Tyrosine-protein kinase receptor RETProto-oncogene tyrosine-protein kinase receptor Ret
Eli Lilly and Co
19 catalysts
Marketed
vandetanib
Caprelsa (vandetanib)
Medullary Thyroid Cancer
Genzyme Corp
19 catalysts
Marketed
cemiplimab
Libtayo (cemiplimab-rwlc)
Melanoma
Programmed cell death protein 1
$REGNREGENERON PHARMACEUTICALS, INC.
17 catalysts
Marketed
(daratumumab + hyaluronidase (human recombinant))
Darzalex Faspro ((daratumumab + hyaluronidase (human recombinant)-fihj))
Multiple Myeloma (Kahler Disease)
Janssen Biotech Inc
16 catalysts
Marketed
IDARUBICIN HYDROCHLORIDE
IDARUBICIN HYDROCHLORIDE (IDARUBICIN HYDROCHLORIDE)
DNA topoisomerase 2-alpha
$PFEPFIZER INC
15 catalysts
Marketed
apalutamide
Erleada (apalutamide [INN])
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
$JNJJOHNSON & JOHNSON
15 catalysts
Marketed
obinutuzumab
Gazyva (obinutuzumab)
Systemic Lupus Erythematosus
B-lymphocyte antigen CD20
F. Hoffmann-La Roche Ltd
14 catalysts
Marketed
trastuzumab emtansine
Kadcyla (trastuzumab emtansine)
Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer (HER2+ Breast…
Receptor tyrosine-protein kinase erbB-2Tubulin
Genentech Inc
14 catalysts
Marketed
CALQUENCE
CALQUENCE (ACALABRUTINIB)
Tyrosine-protein kinase BTK
$AZNASTRAZENECA PLC
13 catalysts
Marketed
asciminib hydrochloride
Scemblix (asciminib hydrochloride)
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia)
$NVSNOVARTIS AG
13 catalysts